Washed microbiota transplantation effectively treats a case of acute severe ulcerative colitis combined with viral myocarditis

Abstract

Viral myocarditis is a rare but life-threatening complication in patients with ulcerative colitis. Management of myocarditis is primarily supportive, because there are currently no established targeted therapies. Recent studies have increasingly highlighted the association between the gut microbiota and myocarditis. Here, we report a case of acute severe ulcerative colitis complicated by cytomegalovirus and Epstein-Barr virus co-infections that led to viral myocarditis. The patient experienced rapid remission of both intestinal and cardiac symptoms following washed microbiota transplantation, suggesting this intervention may serve as a potential alternative treatment for these life-threatening conditions.

Keywords

fecal microbiota transplant / microbiome / cytomegalovirus / Epstein-Barr virus / ulcerative colitis / viral myocarditis

Fundings

This work received no funding from any source.

Acknowledgments

We acknowledge Dr. Shushu Zhu for her professional guidance on cardiology.

References

[1] Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: A review[J]. JAMA, 2023, 329(13): 1098-1113. doi: 10.1001/jama.2023.3371

[2] Leone O, Pieroni M, Rapezzi C, et al. The spectrum of myocarditis: From pathology to the clinics[J]. Virchows Arch, 2019, 475(3): 279-301. doi: 10.1007/s00428-019-02615-8

[3] Toruner M, Loftus Jr EV, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease[J]. Gastroenterology, 2008, 134(4): 929-936. doi: 10.1053/j.gastro.2008.01.012

[4] Tschöpe C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions[J]. Nat Rev Cardiol, 2021, 18(3): 169-193. doi: 10.1038/s41569-020-00435-x

[5] Gil-Cruz C, Perez-Shibayama C, De Martin A, et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy[J]. Science, 2019, 366(6467): 881-886. doi: 10.1126/science.aav3487

[6] Wang J, Zhang X, Yang X, et al. Revitalizing myocarditis treatment through gut microbiota modulation: Unveiling a promising therapeutic avenue[J]. Front Cell Infect Microbiol, 2023, 13: 1191936. doi: 10.3389/fcimb.2023.1191936

[7] Hu X, Zhang W, Wen Q, et al. Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition[J]. Pharmacol Res, 2019, 139: 412-421. doi: 10.1016/j.phrs.2018.11.042

[8] Zhang T, Lu G, Zhao Z, et al. Washed microbiota transplantation vs. manual fecal microbiota transplantation: Clinical findings, animal studies and in vitro screening[J]. Protein Cell, 2020, 11(4): 251-266. doi: 10.1007/s13238-019-00684-8

[9] Lu G, Wen Q, Cui B, et al. Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: The first case report and narrative review[J]. J Biomed Res, 2022, 37(1): 69-76. doi: 10.7555/JBR.36.20220088

[10] Ikeya K, Hanai H, Sugimoto K, et al. The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo endoscopic score[J]. J Crohns Colitis, 2016, 10(3): 286-295. doi: 10.1093/ecco-jcc/jjv210

[11] Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J, 2013, 34(33): 2636-2648. doi: 10.1093/eurheartj/eht210

[12] Steed AL, Christophi GP, Kaiko GE, et al. The microbial metabolite desaminotyrosine protects from influenza through type Ⅰ interferon[J]. Science, 2017, 357(6350): 498-502. doi: 10.1126/science.aam5336

[13] Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system[J]. Nature, 2011, 474(7351): 327-336. doi: 10.1038/nature10213

[14] Tang TWH, Chen HC, Chen CY, et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair[J]. Circulation, 2019, 139(5): 647-659. doi: 10.1161/CIRCULATIONAHA.118.035235

[15] Xu S, Chen H, Zu X, et al. Epstein-Barr virus infection in ulcerative colitis: A clinicopathologic study from a Chinese area[J]. Therap Adv Gastroenterol, 2020, 13: 1756284820930124.

[16] Ciccocioppo R, Racca F, Paolucci S, et al. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement[J]. World J Gastroenterol, 2015, 21(6): 1915-1926. doi: 10.3748/wjg.v21.i6.1915

[17] Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial[J]. Lancet, 2017, 389(10075): 1218-1228. doi: 10.1016/S0140-6736(17)30182-4

[18] de Clercq NC, van den Ende T, Prodan A, et al. Fecal microbiota transplantation from overweight or obese donors in cachectic patients with advanced gastroesophageal cancer: A randomized, double-blind, placebo-controlled, phase Ⅱ study[J]. Clin Cancer Res, 2021, 27(13): 3784-3792. doi: 10.1158/1078-0432.CCR-20-4918

[19] Zhang F, Zuo T, Yeoh YK, et al. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease[J]. Nat Commun, 2021, 12(1): 65. doi: 10.1038/s41467-020-20240-x

[20] Lu G, Wang W, Li P, et al. Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery[J]. Microb Biotechnol, 2022, 15(9): 2439-2449. doi: 10.1111/1751-7915.14074